ReGen Therapeutics, Guildford Clinical Pharmacology Unit Ltd. deal

RGT completed its previously announced acquisition of Guildford in exchange for 7.7 million shares valued at £250,000 ($450,850) (see BioCentury, Oct. 25). ...